Read it and give diagnosis

Reading File

Searching for information on BIRADS III breast ultrasound findings and fibroadenoma to provide a thorough explanation.

search_medical_text

BIRADS III breast ultrasound hypoechoic lesion fibroadenoma diagnosis management

Use of Transcutaneous and Percutaneous Ablation for the Treatment of Benign and Malignant Tumors of the Breast

Page 1

search_medical_image

breast ultrasound fibroadenoma hypoechoic oval well-defined lesion

Hugging Face pmc clinical VQA raw

Page 0

GradeResponse

Scanning Report Summary

Patient: Mrs. Shyba | Age: 40 yrs | Female Investigation: Ultrasonogram of Left Breast (8 MHz high-frequency transducer)

Findings

Parameter	Result
Lesion shape	Well-defined, oval
Echogenicity	Hypoechoic
Size	38 × 19 mm
Location	Left breast parenchyma, 2–3 o'clock position
Cystic areas / Calcification	None
Rest of breast parenchyma	Normal
Skin & subcutaneous tissue	Normal
Duct dilatation	None
Axillary lymph nodes	No significant lymphadenopathy

Radiologist's Impression

BI-RADS III — Possibly Fibroadenoma

What This Means

BI-RADS III (Probably Benign)

BI-RADS 3 means the lesion has a >98% likelihood of being benign and a malignancy risk of <2%.
It does not mean cancer is ruled out — it means the features are most consistent with a benign process.

Fibroadenoma

The most common benign breast tumor in women, especially those of reproductive age. The ultrasound features in this report are classic:

Oval shape (wider than tall)
Well-defined smooth margins
Hypoechoic (darker than surrounding tissue)
No calcification or cystic change
No lymph node involvement

This matches a typical fibroadenoma on ultrasound:

Breast ultrasound showing classic fibroadenoma — well-circumscribed, oval, hypoechoic mass parallel to skin surface

Recommended Next Steps (Standard Protocol for BI-RADS III)

Short-interval follow-up ultrasound in 6 months — to confirm stability of the lesion.
If stable at 6 months → repeat at 12 months, then 24 months → can be downgraded to BI-RADS II (benign).
Core needle biopsy may be considered if:
- The lesion grows significantly
- The patient has high anxiety or requests tissue confirmation
- Clinical features raise additional concern
Treatment is not mandatory for a confirmed benign fibroadenoma unless it causes symptoms (pain, cosmetic concern). Options include percutaneous excision or ultrasound-guided cryoablation if treatment is preferred.

Important: This interpretation is for educational purposes only. Mrs. Shyba should follow up with her referring physician, Dr. P.K. Shajahan, for clinical correlation and a management plan tailored to her individual situation.

This is a shared conversation. Sign in to Orris to start your own chat.